Stockreport

Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene

Revvity, Inc.  (RVTY) 
PDF APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. [Read more]